Scott Wolchko Net Worth & Insider Trades

Scott Wolchko - President and CEO, Fate Therapeutics Inc

As of February 7, 2023

What is Scott Wolchko's Net Worth?

The current estimated net worth of Fate Therapeutics Inc's President and CEO, Scott Wolchko, is estimated to be about $51.73M . Scott Wolchko owns about 385,639 units of Fate Therapeutics Inc common stock. In the last 9 years at Fate Therapeutics Inc, Scott Wolchko has sold an estimated value of $49.2M worth.

What is Scott Wolchko's Past Insider Trading?

Scott Wolchko's largest purchase order was 60,000 units , worth over $253.91K on November 16, 2020. Scott Wolchko's largest sale order was 69,407 units , worth over $8.07M on January 12, 2021. In total, Scott Wolchko has made about 41 transactions over 9 years of their time at Fate Therapeutics Inc. Scott Wolchko usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 45,907 units , worth over $240.55K on January 11, 2023.

Scott Wolchko

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Scott Wolchko's Salary in 2020?

As President and CEO of Fate Therapeutics Inc, Scott Wolchko has a total base salary of $570,000 . Scott Wolchko received compensation valued at about $5,600,167 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of stock awards of $1,451,340 , option awards of $3,222,577 , other earnings, plans or compensations of $356,250 , and

What is Scott Wolchko's' Mailing Address?

  • Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 CA

Fate Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Scott Wolchko 2020 $570,000 - $1,451,340 $3,222,577 $356,250 - $5,600,167
J. Scott Wolchko 2019 $540,000 - $4,137,500 $5,732,955 $310,500 - $10,720,955
J. Scott Wolchko 2018 $516,000 - - $2,756,998 $258,000 - $3,530,998
Edward J. Dulac III 2020 $142,500 $137,917 $1,420,800 $3,786,529 $75,833 $120,000 $5,683,579
Bahram Valamehr, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Bahram Valamehr, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Bahram Valamehr, Ph.D. 2018 $321,865 - - $2,138,235 $117,250 - $2,577,350
Cindy R. Tahl, J.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Cindy R. Tahl, J.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Cindy R. Tahl, J.D. 2018 $350,000 - - $906,465 $122,500 - $1,378,965
Daniel D. Shoemaker, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Daniel D. Shoemaker, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Daniel D. Shoemaker, Ph.D. 2018 $365,000 - - $842,338 $127,750 - $1,335,088
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm

What are Fate Therapeutics Inc's Past Insider Trades?

Fate Therapeutics Inc's most recent insider trade came on April 21, 2023 by Redmile Group Llc and Jeremy Green who bought 276,639 units worth $1.71M . In the last 10 years, insiders at Fate Therapeutics Inc have sold an estimated value of $160.84M and bought an estimated value of $205.58M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO,  Cindy Tahl, General Counsel and Secretary,  and Bahram Valamehr, Chief R&D Officer .

FATE THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...